Duration of Antibiotic Therapy for Pleural Infection
Initial Antibiotic Selection
- The British Thoracic Society recommends that all cases of pleural infection should be treated with intravenous antibiotics initially and must include coverage for Streptococcus pneumoniae 1
- Broader spectrum coverage is required for hospital-acquired infections, as well as those secondary to surgery, trauma, and aspiration 1, 2
- Where possible, antibiotic choice should be guided by microbiological results 1
Duration of Therapy
- The American Thoracic Society recommends that for community-acquired pneumonia with pleural infection, the recommended duration is 1-4 weeks of oral antibiotics after hospital discharge 2
- If residual disease is present, antibiotic therapy should be extended beyond the standard duration 1, 2
Transitioning from IV to Oral Therapy
- Patients should demonstrate clinical and laboratory signs of improvement within 48-72 hours of starting appropriate treatment before transitioning to oral therapy 2
- Improvement criteria include decreased fever, reduced cough, decreased tachypnea, reduced supplemental oxygen dependence, and increased activity and appetite 2
- For adults with severe hospital-acquired pneumonia with pleural infection, if combination therapy with an aminoglycoside-containing regimen is used, the aminoglycoside can be stopped after 5-7 days in responding patients 3
Antibiotic Selection Considerations
- For children under 5 years old, amoxicillin is the first choice for oral antibiotic therapy 2
- For adults and children over 5 years old, oral amoxicillin (90 mg/kg/day in 2 doses up to a maximum of 4 g/day) is the treatment of choice 2
Management Considerations
- Effusions that are enlarging and/or compromising respiratory function should not be managed by antibiotics alone 1
- Early active treatment should be considered as conservative treatment results in prolonged duration of illness and hospital stay 1
Pitfalls and Caveats
- The duration of antibiotic treatment depends on adequate drainage and demonstrated clinical response for each patient 2